Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02737618 · ClinicalTrials.gov registry record · NA

14-Day Cumulative Irritation Patch Test in Subjects With Normal Skin - Chameleon

A NA study of Dermal Irritation, sponsored by Church & Dwight Company.

Completed
Registry status
NA
Development phase
35
Enrollment target
1
Study location

NCT02737618: Completed NA study of Dermal Irritation, sponsored by Church & Dwight Company.

NCT02737618 is a NA study of Dermal Irritation that has completed, run by Church & Dwight Company. The registered enrollment target is 35 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02737618, a NA study of Dermal Irritation, has completed, sponsored by Church & Dwight Company.

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target
1
Study location

Study Summary

to determine the ability of the test article to cause irritation to the skin of humans under controlled patch test conditions

Conditions Studied

Interventions

  • DEVICE Trojan "Chameleon" Personal Lubricant

Study Locations (1)

New Jersey

  • TKL Research Inc - Fair Lawn

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2016-02
Est. Completion 2016-03
Phase NA
Church & Dwight Company

19 total trials

What the finished NCT02737618 record still lists

NCT02737618 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Dermal Irritation appearing as the primary indexed condition, and to 1 intervention - of which Trojan "Chameleon" Personal Lubricant is the first listed.

NCT02737618 reports a single indexed study location in New Jersey.

Frequently Asked Questions

What is clinical trial NCT02737618 about?

NCT02737618 is a clinical study titled "14-Day Cumulative Irritation Patch Test in Subjects With Normal Skin - Chameleon". to determine the ability of the test article to cause irritation to the skin of humans under controlled patch test conditions

What is the current status of trial NCT02737618?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2016-02. Estimated completion is 2016-03.

What conditions does trial NCT02737618 study?

This clinical trial studies the following conditions: Dermal Irritation.

What interventions are being tested in trial NCT02737618?

The interventions under investigation include: Trojan "Chameleon" Personal Lubricant (DEVICE).

Who is sponsoring clinical trial NCT02737618?

This trial is sponsored by Church & Dwight Company, which has 19 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02737618 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT02737618's enrollment target sits among peer trials

35 1564th of 2000 higher than 431 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01697371 · 35 participants · NA

    Proton Therapy in the Treatment of Liver Metastases

  • NCT01940757 · 35 participants · Phase 1

    Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae

  • NCT02235857 · 35 participants · NA

    Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

  • NCT02637934 · 35 participants · Phase 1

    Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02737618, the US trial registry maintained by the National Library of Medicine. NCT02737618 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.